[Comparative study of a single dose of the pyrimethamine-sulfametopyrazine combination and chloroquine in the treatment of malaria attacks caused by Plasmodium falciparum in semi-immune patients in endemic areas (study carried out in Bobo-Dioulasso, Upper Volta)].
D002050:Burkina Faso; D002738:Chloroquine / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage* / Q000627:therapeutic use; D011739:Pyrimethamine / Q000008:administration & dosage* / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use
D011719:Pyrazines; D013449:Sulfonamides; D002738:Chloroquine; D011739:Pyrimethamine
Etude comparative d'une prise unique de l'association pryiméthamine-sulfamétopyrazine et de chloroquine dans le traitement de l'accès paulstre à P. falciparum chez les sujets semi-immuns en zone d'endémie (étude menée à Bobo-Dioulasso, Haute-Volta.